Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Roth

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
ANZ Journal of Surgery|April 24, 2023
Immune mediated colitis: a surgical perspectiveKhang Duy Ricky Le, Kay Tai Choy, Sara Roth, et al.
Annals of Surgical Oncology|July 25, 2018
An Update on Immunotherapy for Solid Tumors: A ReviewToan Pham, Sara Roth, Joseph Kong, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 10, 2019
Novel Vaccine Targeting Colonic Adenoma: a Pre-clinical ModelToan Pham, Sandra Carpinteri, Shienny Sampurno, et al.
Experimental Dermatology|July 16, 2015
A recombinant fusion protein derived from dog hookworm inhibits autoantibody-induced dermal-epidermal separation ex vivoAnnette Kemmer, Katja Bieber, Aida Abadpour, et al.
Contemporary Clinical Trials Communications|October 26, 2019
First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427)Toan Pham, Lloyd Pereira, Sara Roth, et al.
Langenbeck'S Archives of Surgery|October 10, 2023
Use of patient-derived explants as a preclinical model for precision medicine in colorectal cancer: A scoping reviewMilton Mui, Molly Clark, Tamara M S H Vu, et al.
Nature Communications|February 17, 2026
High efficiency CRISPR knock-in demonstrates that TCF1 is insufficient to reverse T cell exhaustionMaria N de Menezes, Amanda X Y Chen, Nihali Kulkarni, et al.
Annals of Surgical Oncology|July 6, 2022
Effect of Surgical Humidification on Inflammation and Peritoneal Trauma in Colorectal Cancer Surgery: A Randomized Controlled TrialShienny Sampurno, Timothy Chittleborough, Meara Dean, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2025
The Ave-Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal CancerMichael Michael, Rachel Wong, Sanjeev Gill, et al.
Heliyon|January 15, 2025
A non-randomised open-label exploratory 'window of opportunity' study of TG02 treatment in patients with locally advanced primary and recurrent <i>RAS</i> mutant colorectal cancerSara Roth, Kasmira Claire Wilson, Robert George Ramsay, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
ANZ Journal of Surgery|April 24, 2023
Immune mediated colitis: a surgical perspectiveKhang Duy Ricky Le, Kay Tai Choy, Sara Roth, et al.
Annals of Surgical Oncology|July 25, 2018
An Update on Immunotherapy for Solid Tumors: A ReviewToan Pham, Sara Roth, Joseph Kong, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 10, 2019
Novel Vaccine Targeting Colonic Adenoma: a Pre-clinical ModelToan Pham, Sandra Carpinteri, Shienny Sampurno, et al.
Experimental Dermatology|July 16, 2015
A recombinant fusion protein derived from dog hookworm inhibits autoantibody-induced dermal-epidermal separation ex vivoAnnette Kemmer, Katja Bieber, Aida Abadpour, et al.
Contemporary Clinical Trials Communications|October 26, 2019
First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427)Toan Pham, Lloyd Pereira, Sara Roth, et al.
Langenbeck'S Archives of Surgery|October 10, 2023
Use of patient-derived explants as a preclinical model for precision medicine in colorectal cancer: A scoping reviewMilton Mui, Molly Clark, Tamara M S H Vu, et al.
Nature Communications|February 17, 2026
High efficiency CRISPR knock-in demonstrates that TCF1 is insufficient to reverse T cell exhaustionMaria N de Menezes, Amanda X Y Chen, Nihali Kulkarni, et al.
Annals of Surgical Oncology|July 6, 2022
Effect of Surgical Humidification on Inflammation and Peritoneal Trauma in Colorectal Cancer Surgery: A Randomized Controlled TrialShienny Sampurno, Timothy Chittleborough, Meara Dean, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2025
The Ave-Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal CancerMichael Michael, Rachel Wong, Sanjeev Gill, et al.
Heliyon|January 15, 2025
A non-randomised open-label exploratory 'window of opportunity' study of TG02 treatment in patients with locally advanced primary and recurrent <i>RAS</i> mutant colorectal cancerSara Roth, Kasmira Claire Wilson, Robert George Ramsay, et al.
Pageof 2